TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Alfimed AS
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
1,886
|
1,723
|
1,952 |
| Financial expenses |
78
|
0
|
0 |
| Earnings before taxes |
309
|
435
|
727 |
| Total assets |
870
|
924
|
1,111 |
| Current assets |
851
|
903
|
1,097 |
| Current liabilities |
590
|
577
|
827 |
| Equity capital |
279
|
347
|
284 |
| - share capital |
9
|
9
|
10 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
32.1%
|
37.6%
|
25.6% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
16.4%
|
25.2%
|
37.2% |
| Return on assets (ROA) |
44.5%
|
47.1%
|
65.4% |
| Current ratio |
144.2%
|
156.5%
|
132.6% |
| Return on equity (ROE) |
110.8%
|
125.4%
|
256.0% |
| Change turnover |
272
|
-126
|
575 |
| Change turnover % |
17%
|
-7%
|
42% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.